Chronic Rhinosinusitis with Nasal Polyps (CRSwNP) Latest Advances

Find the Latest Research About Chronic Rhinosinusitis with Nasal Polyps (CRSwNP)

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 5738 publications

Acute-onset dysphagia: an uncommon presentation of myasthenia crisis.

Acute-onset dysphagia: an uncommon presentation of myasthenia crisis.

Journal: BMJ case reports
Published: September 05, 2026

Bacterial Profile Stability of Middle Meatus Following Endoscopic Sinus Surgery: A Prospective Pilot Study.

Bacterial Profile Stability of Middle Meatus Following Endoscopic Sinus Surgery: A Prospective Pilot Study.

Journal: American journal of rhinology & allergy
Published: August 30, 2026

ALOX15-driven ω-6 fatty acid metabolism promotes type 2 inflammation in eosinophilic chronic rhinosinusitis with nasal polyps.

ALOX15-driven ω-6 fatty acid metabolism promotes type 2 inflammation in eosinophilic chronic rhinosinusitis with nasal polyps.

Journal: The journal of allergy and clinical immunology. Global
Published: August 30, 2026

Dupilumab versus omalizumab in chronic rhinosinusitis with nasal polyps and asthma: a plain language summary.

Dupilumab versus omalizumab in chronic rhinosinusitis with nasal polyps and asthma: a plain language summary.

Journal: Expert opinion on biological therapy
Published: August 26, 2026

AI-derived Histopathological Signatures Are Associated With Response to Mepolizumab in Chronic Rhinosinusitis With Nasal Polyps.

AI-derived Histopathological Signatures Are Associated With Response to Mepolizumab in Chronic Rhinosinusitis With Nasal Polyps.

Journal: American journal of rhinology & allergy
Published: August 20, 2026

VCAM-1 Serves as a Biomarker for Discriminating Eosinophilic CRSwNP and Regulates IL-13-Induced Vascular Remodeling.

VCAM-1 Serves as a Biomarker for Discriminating Eosinophilic CRSwNP and Regulates IL-13-Induced Vascular Remodeling.

Journal: American journal of rhinology & allergy
Published: August 18, 2026

Effects of Glycemic Status and Antidiabetic Agents on the Recurrence of Chronic Rhinosinusitis with Nasal Polyps: A Multicenter Study.

Effects of Glycemic Status and Antidiabetic Agents on the Recurrence of Chronic Rhinosinusitis with Nasal Polyps: A Multicenter Study.

Journal: American journal of rhinology & allergy
Published: August 17, 2026

Outcomes of Biologic Switching in Chronic Rhinosinusitis With Nasal Polyps.

Outcomes of Biologic Switching in Chronic Rhinosinusitis With Nasal Polyps.

Journal: American journal of rhinology & allergy
Published: August 14, 2026

Effectiveness of mepolizumab in eosinophilic asthma and chronic rhinosinusitis with nasal polyps.

Effectiveness of mepolizumab in eosinophilic asthma and chronic rhinosinusitis with nasal polyps.

Journal: Rhinology
Published: August 11, 2026

Baseline EPOS 2020 eligibility and real-world outcomes of dupilumab in CRSwNP: a longitudinal cohort study.

Baseline EPOS 2020 eligibility and real-world outcomes of dupilumab in CRSwNP: a longitudinal cohort study.

Journal: Rhinology
Published: August 11, 2026

Early postoperative reactionary nasal polyps following endoscopic sinus surgery in chronic rhinosinusitis: a prospective observational study.

Early postoperative reactionary nasal polyps following endoscopic sinus surgery in chronic rhinosinusitis: a prospective observational study.

Journal: The Journal of laryngology and otology
Published: August 06, 2026

Healthcare Utilization After Biologic Initiation for Chronic Rhinosinusitis.

Healthcare Utilization After Biologic Initiation for Chronic Rhinosinusitis.

Journal: American journal of rhinology & allergy
Published: August 05, 2026
Showing 1-12 of 5,738

Last Updated: 09/26/2026